Committed under
Immunoshield Therapeutics Inc.
$1.2 Million committed in all years on record · 0.0% of the program
- Full records
- Immunoshield Therapeutics Inc. → everything they’re paid, across every program and agencyDiabetes, Digestive, and Kidney Diseases Extramural Research → the whole program, every recipientDepartment of Health and Human Services → everything they pay out
By fiscal year
Diabetes, Digestive, and Kidney Diseases Extramural Research dollars committed to Immunoshield Therapeutics Inc., per fiscal year.
* FY2026 is year-to-date — the fiscal year is still in progress, so its total is still filling in. The striped band and dashed line mark that provisional stretch.
Awards
The largest awards to Immunoshield Therapeutics Inc. under this program.
Hydrogel Injection Molded Islet Macroencapsulation Devices to Treat Diabetes in a Non-human Primate Model - Project Summary/abstract Type 1 …
Sep 19, 2025$913,868
Islet Dosing and Loading Density in Injection Molded Macroencapsulation Devices - Project Summary/abstract: Clinical Islet Transplantation I…
How to read these numbers
- Just these two
Every figure is money committed to this recipient under this one program — nothing they get anywhere else, from this program or any other.
- Totals by action year
The aggregates reflect the fiscal year picked at the top, counted in the year each action happened.
- “Active in FY X”
The award list shows every award between the two with an action that year, at its full lifetime value — so a single award's amount can top that year's committed total.
- From FY2018 on
Pairing pages start at fiscal year 2018, the first year of complete assistance reporting.
- The colored bars
Every bar on this page splits by how the money moves:
Direct paymentsGrants